{"id":2759,"date":"2024-12-11T05:55:43","date_gmt":"2024-12-11T04:55:43","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/"},"modified":"2024-12-11T05:55:44","modified_gmt":"2024-12-11T04:55:44","slug":"benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/","title":{"rendered":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/benralizumab-beneficia.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2024\/benralizumab-beneficia.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Le benralizumab peut \u00eatre utilis\u00e9 pour le traitement des exacerbations aigu\u00ebs \u00e0 \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique (MPOC), selon une \u00e9tude publi\u00e9e en ligne le 27 novembre dans <i>La m\u00e9decine respiratoire du Lancet<\/i>.<\/p>\n<p>Sanjay Ramakrishnan, MBBS, de l&rsquo;Universit\u00e9 d&rsquo;Australie occidentale \u00e0 Perth, et ses coll\u00e8gues ont recrut\u00e9 des patients pr\u00e9sentant un nombre d&rsquo;\u00e9osinophiles sanguins \u2265 300 cellules\/\u00b5L au moment d&rsquo;une exacerbation de l&rsquo;asthme ou de la BPCO et les ont assign\u00e9s au hasard pour recevoir un traitement aigu avec 30 mg de prednisolone. une fois par jour pendant cinq jours et 100 mg de benralizumab par injection sous-cutan\u00e9e une fois (groupe BENRA plus PRED\u00a0; 52 patients); comprim\u00e9s placebo pendant cinq jours plus 100 mg de benralizumab en injection sous-cutan\u00e9e une fois (groupe BENRA\u00a0; 53 patients)\u00a0; ou prednisolone 30 mg une fois par jour pendant cinq jours plus une injection sous-cutan\u00e9e de placebo une fois (groupe PRED\u00a0; 53 patients).<\/p>\n<p>La proportion d&rsquo;\u00e9checs de traitement sur 90 jours et les sympt\u00f4mes totaux de l&rsquo;\u00e9chelle visuelle analogique (EVA) au jour 28 ont \u00e9t\u00e9 compar\u00e9s dans les groupes BENRA regroup\u00e9s et le groupe PRED.<\/p>\n<p>Les chercheurs ont constat\u00e9 que des \u00e9checs th\u00e9rapeutiques se sont produits chez 74 et 45 % des patients des groupes PRED et BENRA, respectivement, \u00e0 90 jours (rapport de cotes, 0,26). La diff\u00e9rence moyenne totale de l&rsquo;EVA \u00e9tait de 49 mm au jour 28, en faveur des groupes BENRA regroup\u00e9s. Aucun \u00e9v\u00e9nement ind\u00e9sirable mortel n&rsquo;est survenu et le benralizumab a \u00e9t\u00e9 bien tol\u00e9r\u00e9.<\/p>\n<p>\u00ab\u00a0L&rsquo;\u00e9tude ABRA (Acute exacerbations approved with BenRAlizumab) est le premier essai \u00e0 cibler le trait \u00e9osinophile traitable, lors des exacerbations\u00a0\u00bb, \u00e9crivent les auteurs. \u00ab\u00a0Cette \u00e9tude montre que le benralizumab est efficace comme traitement aigu de l&rsquo;exacerbation \u00e9osinophile.\u00a0\u00bb<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le benralizumab peut \u00eatre utilis\u00e9 pour le traitement des exacerbations aigu\u00ebs \u00e0 \u00e9osinophiles de l&rsquo;asthme<\/p>\n","protected":false},"author":1,"featured_media":2760,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[3007,3006,250,3009,3008,2440,49,248,2634,8,2276],"class_list":["post-2759","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-benefique","tag-benralizumab","tag-chronique","tag-eosinophiles","tag-exacerbations","tag-lasthme","tag-les","tag-maladie","tag-obstructive","tag-pour","tag-pulmonaire","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&#039;asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&#039;asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Le benralizumab peut \u00eatre utilis\u00e9 pour le traitement des exacerbations aigu\u00ebs \u00e0 \u00e9osinophiles de l&rsquo;asthme\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-11T04:55:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-11T04:55:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"773\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique\",\"datePublished\":\"2024-12-11T04:55:43+00:00\",\"dateModified\":\"2024-12-11T04:55:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\"},\"wordCount\":312,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg\",\"keywords\":[\"b\u00e9n\u00e9fique\",\"Benralizumab\",\"chronique\",\"\u00e9osinophiles\",\"exacerbations\",\"lasthme\",\"Les\",\"maladie\",\"obstructive\",\"pour\",\"pulmonaire\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\",\"name\":\"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg\",\"datePublished\":\"2024-12-11T04:55:43+00:00\",\"dateModified\":\"2024-12-11T04:55:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg\",\"width\":1280,\"height\":773,\"caption\":\"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/","og_locale":"fr_FR","og_type":"article","og_title":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org","og_description":"Le benralizumab peut \u00eatre utilis\u00e9 pour le traitement des exacerbations aigu\u00ebs \u00e0 \u00e9osinophiles de l&rsquo;asthme","og_url":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/","og_site_name":"RVH-Synergie","article_published_time":"2024-12-11T04:55:43+00:00","article_modified_time":"2024-12-11T04:55:44+00:00","og_image":[{"width":1280,"height":773,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique","datePublished":"2024-12-11T04:55:43+00:00","dateModified":"2024-12-11T04:55:44+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/"},"wordCount":312,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg","keywords":["b\u00e9n\u00e9fique","Benralizumab","chronique","\u00e9osinophiles","exacerbations","lasthme","Les","maladie","obstructive","pour","pulmonaire"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/","url":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/","name":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg","datePublished":"2024-12-11T04:55:43+00:00","dateModified":"2024-12-11T04:55:44+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1733892943_Benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de.jpg","width":1280,"height":773,"caption":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l'asthme et de la maladie pulmonaire obstructive chronique"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/benralizumab-benefique-pour-les-exacerbations-eosinophiles-de-lasthme-et-de-la-maladie-pulmonaire-obstructive-chronique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Benralizumab b\u00e9n\u00e9fique pour les exacerbations \u00e9osinophiles de l&rsquo;asthme et de la maladie pulmonaire obstructive chronique"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=2759"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2759\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/2760"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=2759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=2759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=2759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}